{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:21:45Z","timestamp":1792653705904,"version":"4.5.0"},"posted":{"date-parts":[[2026,5,21]]},"group-title":"Cancer Biology","reference-count":100,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,5,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is an intractable disease with few effective treatment options. PDAC is characterized by a dense, fibro-inflammatory tumor microenvironment (TME) consisting mainly of cancer-associated fibroblasts (CAFs) and a CAF-generated collagen-rich extracellular matrix (ECM). As the ECM has profound impacts on tumor progression and therapy response, it is critical that we understand the mechanisms underlying ECM deposition and remodeling. In addition to a highly fibrotic and reactive TME, a hallmark of PDAC is pain. 93% of PDAC patients experience pain, and \u223c70% are prescribed opioids for pain management during the course of their cancer treatment. Despite epidemiological evidence linking opioid use with diminished patient survival, how opioids impact tumor biology remains largely unknown. We now provide evidence that both endogenous and exogenous opioids drive ECM remodeling in the PDAC TME. We find that the commonly prescribed opioid morphine promotes the development of poorly differentiated tumors and increases collagen bundling and maturation in a mouse model of PDAC. Accordingly, RNA sequencing reveals that morphine induces significant upregulation of ECM genes and collagen modifying enzymes. We developed a morphine-induced gene signature which correlates significantly with the basal\/mesenchymal subtypes of human PDAC and predicts worse overall survival in PDAC and other tumor types. Mechanistically, pharmacological inhibition and genetic knockdown of the mu opioid receptor (OPRM1) in CAFs attenuates expression of type 1a and type 3a collagens, and the myofibroblastic CAF marker alpha-SMA, demonstrating that opioid signaling is a direct regulator of CAF biology. Additionally, we provide the first evidence that CAFs produce endogenous opioids capable of activating OPRM1 and driving collagen expression. Finally, treatment with the FDA-approved peripherally restricted OPRM1 antagonist methylnaltrexone (MNTX) reduces desmoplasia, tumor weight, and ascites burden in a mouse model of PDAC. Therefore, we have identified a novel opioid-mediated signaling axis driving PDAC desmoplasia and reveal MNTX as a potential therapeutic to inhibit both exogenous and endogenous opioid-induced ECM remodeling and tumor aggressiveness.<\/jats:p>","DOI":"10.64898\/2026.05.20.726559","type":"posted-content","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:30:15Z","timestamp":1779424215000},"source":"Crossref","is-referenced-by-count":1,"title":["A targetable opioid\/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancer"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6280-0324","authenticated-orcid":false,"given":"Kathryn E.","family":"Maraszek","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"},{"name":"Experimental Therapeutics Graduate Program, State University of New York at Buffalo and Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3999-8707","authenticated-orcid":false,"given":"Arwen A.","family":"Tisdale","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-7151","authenticated-orcid":false,"given":"Hunter D.","family":"Reavis","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2237-1016","authenticated-orcid":false,"given":"Xiaozhuo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Cortes","family":"Gomez","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"},{"name":"Department of Biostatistics, State University of New York at Buffalo, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9956-1163","authenticated-orcid":false,"given":"Aleksandr","family":"Dolskii","sequence":"additional","affiliation":[{"name":"Cancer Signaling and Microenvironment Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA"},{"name":"Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caneta","family":"Brown","sequence":"additional","affiliation":[{"name":"Cancer Signaling and Microenvironment Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA"},{"name":"Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daksh","family":"Thakkar","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9102-9237","authenticated-orcid":false,"given":"Maura","family":"Dungan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Adhikari","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5332-715X","authenticated-orcid":false,"given":"Emily","family":"Mackey","sequence":"additional","affiliation":[{"name":"Comparative Oncology Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3652-5311","authenticated-orcid":false,"given":"Janusz","family":"Franco-Barraza","sequence":"additional","affiliation":[{"name":"Cancer Signaling and Microenvironment Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA"},{"name":"Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3513-1214","authenticated-orcid":false,"given":"Brooke A.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia"},{"name":"School of Clinical Medicine, Faculty of Medicine, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5514-7080","authenticated-orcid":false,"given":"Paul","family":"Timpson","sequence":"additional","affiliation":[{"name":"Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia"},{"name":"School of Clinical Medicine, Faculty of Medicine, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-1174","authenticated-orcid":false,"given":"Dean G.","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"},{"name":"Experimental Therapeutics Graduate Program, State University of New York at Buffalo and Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1564-3562","authenticated-orcid":false,"given":"Nina","family":"Steele","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1452-9576","authenticated-orcid":false,"given":"Edna","family":"Cukierman","sequence":"additional","affiliation":[{"name":"Cancer Signaling and Microenvironment Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA"},{"name":"Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8189-5568","authenticated-orcid":false,"given":"Michael E.","family":"Feigin","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"},{"name":"Experimental Therapeutics Graduate Program, State University of New York at Buffalo and Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026052602400522000_2026.05.20.726559v1.1","unstructured":"Cancer Stat Facts: Pancreatic Cancer. SEER: seer.cancer.gov."},{"key":"2026052602400522000_2026.05.20.726559v1.2","doi-asserted-by":"crossref","unstructured":"Roth, S. , et al., Pancreatic cancer. Nat Rev Dis Primers, 2026. 12(1).","DOI":"10.1038\/s41572-026-00708-8"},{"key":"2026052602400522000_2026.05.20.726559v1.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13027"},{"key":"2026052602400522000_2026.05.20.726559v1.4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70043"},{"key":"2026052602400522000_2026.05.20.726559v1.5","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-0155"},{"key":"2026052602400522000_2026.05.20.726559v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.02.014"},{"key":"2026052602400522000_2026.05.20.726559v1.7","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10330-y"},{"key":"2026052602400522000_2026.05.20.726559v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0300-1"},{"key":"2026052602400522000_2026.05.20.726559v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms16031"},{"issue":"9","key":"2026052602400522000_2026.05.20.726559v1.10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1158\/2767-9764.CRC-21-0147","article-title":"NetrinG1(+) cancer-associated fibroblasts generate unique extracellular vesicles that support the survival of pancreatic cancer cells under nutritional stress","volume":"2","year":"2022","journal-title":"Cancer Res Commun"},{"key":"2026052602400522000_2026.05.20.726559v1.11","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0775"},{"key":"2026052602400522000_2026.05.20.726559v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.08.010"},{"key":"2026052602400522000_2026.05.20.726559v1.13","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.54"},{"key":"2026052602400522000_2026.05.20.726559v1.14","doi-asserted-by":"crossref","unstructured":"Weniger, M. , K.C. Honselmann , and A.S. Liss , The Extracellular Matrix and Pancreatic Cancer: A Complex Relationship. Cancers (Basel), 2018. 10(9).","DOI":"10.3390\/cancers10090316"},{"key":"2026052602400522000_2026.05.20.726559v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2010.04.004"},{"key":"2026052602400522000_2026.05.20.726559v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4082"},{"key":"2026052602400522000_2026.05.20.726559v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2015.01.004"},{"issue":"6","key":"2026052602400522000_2026.05.20.726559v1.18","doi-asserted-by":"crossref","first-page":"e971","DOI":"10.1002\/onco.13796","article-title":"Pancreas Cancer-Associated Pain Management","volume":"26","year":"2021","journal-title":"Oncologist"},{"issue":"11","key":"2026052602400522000_2026.05.20.726559v1.19","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/cam4.4610","article-title":"Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015","volume":"11","year":"2022","journal-title":"Cancer Med"},{"key":"2026052602400522000_2026.05.20.726559v1.20","doi-asserted-by":"crossref","unstructured":"Boland, J.W ., Effect of Opioids on Survival in Patients with Cancer. Cancers (Basel), 2022. 14(22).","DOI":"10.3390\/cancers14225720"},{"key":"2026052602400522000_2026.05.20.726559v1.21","doi-asserted-by":"crossref","first-page":"135661","DOI":"10.1016\/j.neulet.2021.135661","article-title":"Opioids and cancer prognosis: A summary of the clinical evidence","volume":"746","year":"2021","journal-title":"Neurosci Lett"},{"issue":"5","key":"2026052602400522000_2026.05.20.726559v1.22","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s11010-022-04377-5","article-title":"Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression","volume":"477","year":"2022","journal-title":"Mol Cell Biochem"},{"key":"2026052602400522000_2026.05.20.726559v1.23","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31820568af"},{"key":"2026052602400522000_2026.05.20.726559v1.24","doi-asserted-by":"crossref","unstructured":"McIlvried, L.A. , et al., Morphine treatment restricts response to immunotherapy in oral squamous cell carcinoma. J Immunother Cancer, 2024. 12(11).","DOI":"10.1136\/jitc-2024-009962"},{"issue":"1-2","key":"2026052602400522000_2026.05.20.726559v1.25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jpain.2019.05.017","article-title":"A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models","volume":"21","year":"2020","journal-title":"J Pain"},{"key":"2026052602400522000_2026.05.20.726559v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3398"},{"key":"2026052602400522000_2026.05.20.726559v1.27","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2344"},{"key":"2026052602400522000_2026.05.20.726559v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/nature16965"},{"key":"2026052602400522000_2026.05.20.726559v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.3014"},{"key":"2026052602400522000_2026.05.20.726559v1.30","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-24-2183"},{"key":"2026052602400522000_2026.05.20.726559v1.31","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.07.030184.001255"},{"issue":"12","key":"2026052602400522000_2026.05.20.726559v1.32","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.tips.2020.10.001","article-title":"Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype","volume":"41","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"2026052602400522000_2026.05.20.726559v1.33","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12473"},{"key":"2026052602400522000_2026.05.20.726559v1.34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00431"},{"issue":"11","key":"2026052602400522000_2026.05.20.726559v1.35","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1111\/bph.15028","article-title":"GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets","volume":"177","year":"2020","journal-title":"Br J Pharmacol"},{"key":"2026052602400522000_2026.05.20.726559v1.36","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2014.485"},{"key":"2026052602400522000_2026.05.20.726559v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.11.007"},{"key":"2026052602400522000_2026.05.20.726559v1.38","doi-asserted-by":"crossref","unstructured":"Reavis, H.D. , et al., Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells. JCI Insight, 2024. 9(5).","DOI":"10.1172\/jci.insight.170961"},{"key":"2026052602400522000_2026.05.20.726559v1.39","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0641"},{"key":"2026052602400522000_2026.05.20.726559v1.40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129502"},{"key":"2026052602400522000_2026.05.20.726559v1.41","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2016.680"},{"issue":"18","key":"2026052602400522000_2026.05.20.726559v1.42","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-23-0547","article-title":"Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer","volume":"29","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2026052602400522000_2026.05.20.726559v1.43","doi-asserted-by":"crossref","unstructured":"Reavis, H.D. , et al., Alprazolam reduces inflammatory cytokine production in pancreatic cancer-associated fibroblasts. Cancer Res Commun, 2026.","DOI":"10.1158\/2767-9764.CRC-25-0472"},{"key":"2026052602400522000_2026.05.20.726559v1.44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00470"},{"issue":"1","key":"2026052602400522000_2026.05.20.726559v1.45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.aat.2010.12.008","article-title":"Mu opioid receptors in pain management","volume":"49","year":"2011","journal-title":"Acta Anaesthesiol Taiwan"},{"key":"2026052602400522000_2026.05.20.726559v1.46","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318238bba6"},{"key":"2026052602400522000_2026.05.20.726559v1.47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091577"},{"issue":"5","key":"2026052602400522000_2026.05.20.726559v1.48","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1248\/bpb.b19-00779","article-title":"Morphine Stimulates Migration and Growth and Alleviates the Effects of Chemo Drugs via AMPK-Dependent Induction of Epithelial-Mesenchymal Transition in Esophageal Carcinoma Cells","volume":"43","year":"2020","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"2026052602400522000_2026.05.20.726559v1.49","doi-asserted-by":"crossref","first-page":"e01016","DOI":"10.1002\/prp2.1016","article-title":"Morphine stimulates cervical cancer cells and alleviates cytotoxicity of chemotherapeutic drugs via opioid receptor-dependent and -independent mechanisms","volume":"10","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"2026052602400522000_2026.05.20.726559v1.50","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejca.2021.08.036","article-title":"Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events","volume":"157","year":"2021","journal-title":"Eur J Cancer"},{"issue":"1","key":"2026052602400522000_2026.05.20.726559v1.51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12967-021-02784-8","article-title":"The role of opioids in cancer response to immunotherapy","volume":"19","year":"2021","journal-title":"J Transl Med"},{"key":"2026052602400522000_2026.05.20.726559v1.52","doi-asserted-by":"crossref","unstructured":"Cortellini, A. , et al., Integrated analysis of concomitant medications and oncological outcomes from PD-1\/PD-L1 checkpoint inhibitors in clinical practice. J Immunother Cancer, 2020. 8(2).","DOI":"10.1136\/jitc-2020-001361"},{"issue":"9","key":"2026052602400522000_2026.05.20.726559v1.53","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s12094-019-02282-w","article-title":"Impact of antibiotic use and other concomitant medications on the efficacy of immune checkpoint inhibitors in patients with advanced cancer","volume":"22","year":"2020","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"2026052602400522000_2026.05.20.726559v1.54","doi-asserted-by":"crossref","first-page":"24233","DOI":"10.1038\/s41598-024-75089-7","article-title":"Bidirectional effects of morphine on pancreatic cancer progression via the p38\/JNK pathway","volume":"14","year":"2024","journal-title":"Sci Rep"},{"key":"2026052602400522000_2026.05.20.726559v1.55","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2023-104511"},{"key":"2026052602400522000_2026.05.20.726559v1.56","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443130-00004"},{"key":"2026052602400522000_2026.05.20.726559v1.57","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200060010-00008"},{"key":"2026052602400522000_2026.05.20.726559v1.58","doi-asserted-by":"publisher","DOI":"10.3389\/FNINT.2022.899637\/BIBTEX"},{"issue":"2","key":"2026052602400522000_2026.05.20.726559v1.59","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00540-009-0845-1","article-title":"Morphine enhances tissue content of collagen and increases wound tensile strength","volume":"24","year":"2010","journal-title":"J Anesth"},{"issue":"9","key":"2026052602400522000_2026.05.20.726559v1.60","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7150\/ijms.23074","article-title":"Morphine Induces Fibroblast Activation through Up-regulation of Connexin 43 Expression: Implication of Fibrosis in Wound Healing","volume":"15","year":"2018","journal-title":"Int J Med Sci"},{"issue":"4","key":"2026052602400522000_2026.05.20.726559v1.61","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbrc.2020.06.137","article-title":"Dopamine receptor D3 agonist (Pramipexole) reduces morphine-induced cardiac fibrosis","volume":"529","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2026052602400522000_2026.05.20.726559v1.62","first-page":"225","article-title":"Effect of morphine on renomedullary interstitial cell proliferation and matrix accumulation","volume":"77","year":"1997","journal-title":"Nephron"},{"issue":"1","key":"2026052602400522000_2026.05.20.726559v1.63","doi-asserted-by":"crossref","first-page":"2310291","DOI":"10.1080\/19490976.2024.2310291","article-title":"Prescription opioids induced microbial dysbiosis worsens severity of chronic pancreatitis and drives pain hypersensitivity","volume":"16","year":"2024","journal-title":"Gut Microbes"},{"key":"2026052602400522000_2026.05.20.726559v1.64","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.120303"},{"issue":"2","key":"2026052602400522000_2026.05.20.726559v1.65","first-page":"37","article-title":"Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer","volume":"2010","year":"2010","journal-title":"Open Access J Clin Trials"},{"key":"2026052602400522000_2026.05.20.726559v1.66","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(01)00160-6"},{"key":"2026052602400522000_2026.05.20.726559v1.67","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00414.2009"},{"issue":"9","key":"2026052602400522000_2026.05.20.726559v1.68","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3748\/wjg.v20.i9.2218","article-title":"Opioid growth factor and the treatment of human pancreatic cancer: a review","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2026052602400522000_2026.05.20.726559v1.69","doi-asserted-by":"crossref","first-page":"105785","DOI":"10.1016\/j.intimp.2019.105785","article-title":"Interaction of opioid growth factor (OGF) and opioid antagonist and their significance in cancer therapy","volume":"75","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"2026052602400522000_2026.05.20.726559v1.70","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez, M.L. , F.D. Rodr\u00edguez , and R. Cove\u00f1as , Involvement of the Opioid Peptide Family in Cancer Progression. Biomedicines, 2023. 11(7).","DOI":"10.3390\/biomedicines11071993"},{"key":"2026052602400522000_2026.05.20.726559v1.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjao.2023.100141"},{"key":"2026052602400522000_2026.05.20.726559v1.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.04.021"},{"key":"2026052602400522000_2026.05.20.726559v1.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.04.005"},{"key":"2026052602400522000_2026.05.20.726559v1.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.08.007"},{"key":"2026052602400522000_2026.05.20.726559v1.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.01.007"},{"issue":"9","key":"2026052602400522000_2026.05.20.726559v1.76","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s43018-023-00614-y","article-title":"A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer","volume":"4","year":"2023","journal-title":"Nat Cancer"},{"key":"2026052602400522000_2026.05.20.726559v1.77","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms.3516"},{"key":"2026052602400522000_2026.05.20.726559v1.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2016.05.002"},{"key":"2026052602400522000_2026.05.20.726559v1.79","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316451"},{"key":"2026052602400522000_2026.05.20.726559v1.80","doi-asserted-by":"publisher","DOI":"10.1101\/gad.351863.124"},{"key":"2026052602400522000_2026.05.20.726559v1.81","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S221278"},{"issue":"2","key":"2026052602400522000_2026.05.20.726559v1.82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1017\/S147895150707023X","article-title":"A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation","volume":"5","year":"2007","journal-title":"Palliat Support Care"},{"key":"2026052602400522000_2026.05.20.726559v1.83","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K009"},{"issue":"10","key":"2026052602400522000_2026.05.20.726559v1.84","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s11912-022-01295-z","article-title":"Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?","volume":"24","year":"2022","journal-title":"Curr Oncol Rep"},{"issue":"11","key":"2026052602400522000_2026.05.20.726559v1.85","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1002\/jcp.30421","article-title":"Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor","volume":"236","year":"2021","journal-title":"J Cell Physiol"},{"key":"2026052602400522000_2026.05.20.726559v1.86","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw317"},{"key":"2026052602400522000_2026.05.20.726559v1.87","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2089"},{"key":"2026052602400522000_2026.05.20.726559v1.88","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2019"},{"key":"2026052602400522000_2026.05.20.726559v1.89","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-10-r106"},{"key":"2026052602400522000_2026.05.20.726559v1.90","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8"},{"key":"2026052602400522000_2026.05.20.726559v1.91","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"2026052602400522000_2026.05.20.726559v1.92","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELS.2015.12.004"},{"key":"2026052602400522000_2026.05.20.726559v1.93","unstructured":"Gene Ontology Consortium, in The Gene Ontology knowledgebase in 2023. 2023: Nucleic Acids Research."},{"key":"2026052602400522000_2026.05.20.726559v1.94","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128"},{"key":"2026052602400522000_2026.05.20.726559v1.95","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw377"},{"key":"2026052602400522000_2026.05.20.726559v1.96","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90"},{"key":"2026052602400522000_2026.05.20.726559v1.97","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mex.2017.10.008","article-title":"A Rapid Extraction Method for mammalian cell cultures, suitable for quantitative immunoblotting analysis of proteins, including phosphorylated GCN2 and eIF2\u03b1","volume":"5","year":"2018","journal-title":"MethodsX"},{"issue":"11","key":"2026052602400522000_2026.05.20.726559v1.98","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s43018-020-00121-4","article-title":"Multimodal Mapping of the Tumor and Peripheral Blood Immune Landscape in Human Pancreatic Cancer","volume":"1","year":"2020","journal-title":"Nat Cancer"},{"key":"2026052602400522000_2026.05.20.726559v1.99","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110569"},{"key":"2026052602400522000_2026.05.20.726559v1.100","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz430"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.05.20.726559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T09:40:21Z","timestamp":1779788421000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.05.20.726559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":100,"URL":"https:\/\/doi.org\/10.64898\/2026.05.20.726559","relation":{},"subject":[],"published":{"date-parts":[[2026,5,21]]},"subtype":"preprint"}}